Modi Rajeev A. has demonstrated a clear selling bias in their trading activity involving Elanco Animal Health (ELAN), with $678,737 in total sales compared to $161,593 in purchases across 35 transactions. The most significant sale occurred on March 1, 2026, when Modi disposed of shares worth $511,500, followed by a $109,273 sale on March 3, 2026. Smaller but consistent sales occurred throughout late 2025 and early 2026, typically in increments of $1,414 to $1,476, suggesting a structured divestment plan. The only recent purchase was a $31,775 acquisition on March 6, 2026, which stands in contrast to the broader liquidation trend.
Modi’s transactions show a concentrated focus on ELAN, with no activity in other securities. The pattern includes periodic sales alongside occasional acquisitions, though the net outflow is substantial. The largest transactions occurred in early March 2026, while smaller, recurring sales date back to at least July 2025. The absence of recent sales filings since March 20, 2026—when Modi acquired $1,476 in shares—could indicate a pause or shift in strategy, though the overall disposition remains weighted toward divestment. The filings reflect methodical activity rather than erratic trading, with a clear emphasis on reducing exposure to ELAN over time.
AI-assisted summary